| For: | Jiang JG, Tang JB, Chen CL, Liu BX, Fu XN, Zhu ZH, Qu W, Cianflone K, Waalkes MP, Wang DW. Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas. World J Gastroenterol 2004; 10(15): 2168-2173 [PMID: 15259059 DOI: 10.3748/wjg.v10.i15.2168] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i15/2168.htm |
| Number | Citing Articles |
| 1 |
J-F. Liu, G. Jamieson, T-C. Wu, S-W. Zhang, Q-Z. Wang, P. Drew. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Diseases of the Esophagus 2006; 19(5) doi: 10.1111/j.1442-2050.2006.00594.x
|
| 2 |
Sarah B Umar, David E Fleischer. Esophageal cancer: epidemiology, pathogenesis and prevention. Nature Clinical Practice Gastroenterology & Hepatology 2008; 5(9) doi: 10.1038/ncpgasthep1223
|
| 3 |
Mark Baguma‐Nibasheka, Christie Barclay, Audrey W. Li, Laurette Geldenhuys, Geoffrey A. Porter, Jonathan Blay, Alan G. Casson, Paul R. Murphy. Selective cyclooxygenase‐2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma. Molecular Carcinogenesis 2007; 46(12) doi: 10.1002/mc.20339
|
| 4 |
Dongyun Zhang, Jingxia Li, Lun Song, Weiming Ouyang, Jimin Gao, Chuanshu Huang. A JNK1/AP-1–Dependent, COX-2 Induction Is Implicated in 12-O-Tetradecanoylphorbol-13-Acetate–Induced Cell Transformation through Regulating Cell Cycle Progression. Molecular Cancer Research 2008; 6(1) doi: 10.1158/1541-7786.MCR-07-0181
|
| 5 |
Gary D. Stoner, Haiyan Qin, Tong Chen, Peter S. Carlton, Miranda E. Rose, Robeena M. Aziz, Rakesh Dixit. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N -nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 2005; 26(9) doi: 10.1093/carcin/bgi111
|
| 6 |
Kyung Mi Lee, Ki Won Lee, Ann M. Bode, Hyong Joo Lee, Zigang Dong. Tpl2 Is a Key Mediator of Arsenite-Induced Signal Transduction. Cancer Research 2009; 69(20) doi: 10.1158/0008-5472.CAN-09-2316
|
| 7 |
Rodolpho L. Cecim, Hicso A. F. Carmo, Maria S. S. Kataoka, Vanessa M. Freitas, Sérgio de Melo Alves Júnior, Erick N. Pedreira, Ruy G. Jaeger, Joao J. V. Pinheiro. Expression of molecules related to AKT pathway as putative regulators of ameloblastoma local invasiveness. Journal of Oral Pathology & Medicine 2014; 43(2) doi: 10.1111/jop.12103
|
| 8 |
Yao Chen, Fang-Xun Liu, Hong Liu. Effects of dietary zinc deficiency on esophageal squamous cell proliferation and the mechanisms involved. World Journal of Gastrointestinal Oncology 2021; 13(11): 1755-1765 doi: 10.4251/wjgo.v13.i11.1755
|
| 9 |
Simona Corrao, Giampiero Rocca, Rita Anzalone, Lorenzo Marasà, Felicia Farina, Giovanni Zummo, Francesco Cappello. Role of CD1A and HSP60 in the antitumoral response of oesophageal cancer. Oncology Reviews 2008; 1(4) doi: 10.1007/s12156-008-0027-7
|
| 10 |
Stefano Cascinu, Mario Scartozzi, Giovanna Carbonari, Chiara Pierantoni, Lorena Verdecchia, Cinzia Mariani, Michela Squadroni, Stefania Antognoli, Rosa Rita Silva, Riccardo Giampieri, Rossana Berardi. COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin. American Journal of Clinical Oncology 2007; 30(5) doi: 10.1097/COC.0b013e318054675c
|
| 11 |
Zhifeng Qu, Xuewei Zheng, Anshun Zhao, Pei Wang, Shegan Gao, Qinan Yin. Mast cell driven immunometabolism as a therapeutic entry point in ESCC. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1830394
|